Skip to content
Bills from the 2017–18 session

Assembly Bill 69

Access to investigational drugs, devices, and biological products and limitations on liability related to their use

Passed the Assembly, then stopped

The Assembly passed it on Mar 7, 2017, but the Senate never voted on it. A bill has to ⁠. To try again, a lawmaker would have to start a new bill.

  1. Introduced, passed

    Feb 13, 2017

  2. Committee, passed

    Approved

  3. Assembly vote, passed

    Passed Mar 7, 2017

  4. Senate vote, stopped here

    Stopped here. The Senate never voted on it.

  5. Governor, not reached

  6. Law, not reached

Latest entry in the official record, Mar 28, 2018: “Failed to concur in pursuant to ⁠”

Read the bill

Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.

What it would have done

Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.

Under this bill, a manufacturer of an investigational drug, device, or biological product may make the investigational drug, device, or biological product available to an eligible patient. Under the bill, an investigational drug, device, or biological product is one that has not yet been approved for use by the federal Food and Drug Administration, but, among other requirements, has successfully completed a phase one clinical trial and remains under investigation or is pending approval by the FDA.

A patient is eligible under the bill if, among other things, the patient has considered all other available treatment options, has received a treating physician's recommendation or prescription order for an investigational drug, device, or biological product, and has given written informed consent for use of the investigational drug, device, or biological product.

Read the full summary

The bill provides a limitation of liability under state law for a manufacturer, distributor, pharmacist, physician or other practitioner, or other person who makes available, delivers, distributes, prescribes, dispenses, or administers an investigational drug, device, or biological product to an eligible patient consistent with the bill's provisions, and who in doing so exercises reasonable care.

Finally, the bill prohibits an official, employee, or agent of the state from blocking or attempting to block an eligible patient's access to an investigational drug, device, or biological product.

Who's behind it

44 lawmakers are its ⁠. 32 are Republicans and 12 are Democrats.

18 more lawmakers ⁠.

See all 62 names

Authors (44)

Signed on in support (18)

Versions and amendments

Every text the Legislature printed for this bill, including proposed changes. Each opens on the Legislature's site.

How lawmakers voted

There were 7 votes on this bill.

Assembly Committee on Health vote on an amendment

Passed, 10 to 2 · Mar 1, 2017

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Report Assembly Substitute Amendment 1 adoption recommended by Committee on Health, Ayes 10, Noes 2”. Official record · This vote on its own page

Assembly Committee on Health vote to recommend it

Passed, 10 to 2 · Mar 1, 2017

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Report passage as amended recommended by Committee on Health, Ayes 10, Noes 2”. Official record · This vote on its own page

Assembly vote on an amendment

Passed, 64 to 34 · Mar 7, 2017

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Assembly Amendment 3 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34”. Official record · This vote on its own page

Assembly vote on an amendment

Passed, 65 to 33 · Mar 7, 2017

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Assembly Amendment 4 to Assembly Substitute Amendment 1 laid on table, Ayes 65, Noes 33”. Official record · This vote on its own page

Assembly vote on an amendment

Passed, 64 to 34 · Mar 7, 2017

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Assembly Amendment 5 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34”. Official record · This vote on its own page

Assembly vote on an amendment

Passed, 64 to 34 · Mar 7, 2017

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Assembly Amendment 6 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34”. Official record · This vote on its own page

Assembly vote to pass it

Passed, 85 to 13 · Mar 7, 2017 · 1 didn't vote

See how each of the 99 representatives voted

D: Democrat, R: Republican

Yes (85)

Didn't vote (1)

Official motion: “PASSAGE”. Official record · This vote on its own page

What happened

  1. Mar 28, 2018

    The session ended, and the bill died with it.

  2. Aug 16, 2017

    The committee held a public hearing.

  3. Mar 9, 2017

    Sent to the Senate Committee on Health and Human Services.

  4. Mar 8, 2017

    The Senate received it.

  5. Mar 7, 2017

    9 more representatives signed on in support.

  6. Mar 7, 2017

    The Assembly passed it, 85 to 13.

  7. Mar 7, 2017

    The Assembly adopted it.

  8. Mar 1, 2017

    Sent to the Assembly Committee on Rules.

  9. Mar 1, 2017

    The committee voted to recommend passing it, 10 to 2.

  10. Feb 22, 2017

    The committee held a public hearing.

  11. Feb 13, 2017

    Sent to the Assembly Committee on Health.

  12. Feb 13, 2017

    Introduced in the Assembly.

See the official record, word for word
  1. Feb 13, 2017 · Assembly

    Introduced by Representatives Snyder, Kleefisch, Hesselbein, Krug, Skowronski, Steffen, Milroy, Kremer, Brandtjen, Pope, Kooyenga, Edming, Mursau, Tittl, Sargent, Horlacher, Kulp, Mason, E. Brooks, Spiros, Bernier, C. Taylor, Vruwink, Novak, R. Brooks, VanderMeer, Jagler, Knodl, Quinn, Anderson, Ballweg, Tauchen, Berceau, Murphy, Subeck, Gannon, Sinicki, Ripp, Katsma, Allen, Doyle, Zamarripa, Tusler, Hutton and Loudenbeck; cosponsored by Senators Moulton, Risser, Carpenter, Johnson, L. Taylor, Cowles, Feyen, Lasee, Craig, Kapenga, Darling, Marklein, Miller, Petrowski, LeMahieu, Harsdorf and Vinehout

  2. Feb 13, 2017 · Assembly

    Read first time and referred to Committee on Health

  3. Feb 22, 2017 · Assembly

    Public hearing held

  4. Feb 28, 2017 · Assembly

    Assembly Amendment 1 offered by Representatives Kolste, Subeck, C. Taylor and Zamarripa

  5. Feb 28, 2017 · Assembly

    Assembly Amendment 2 offered by Representatives Kolste, Subeck, C. Taylor and Zamarripa

  6. Feb 28, 2017 · Assembly

    Assembly Amendment 3 offered by Representatives Subeck, Kolste, C. Taylor and Zamarripa

  7. Feb 28, 2017 · Assembly

    Assembly Substitute Amendment 1 offered by Representative Snyder

  8. Mar 1, 2017 · Assembly

    Assembly Amendment 1 to Assembly Substitute Amendment 1 offered by Representatives Kolste, Subeck, C. Taylor and Zamarripa

  9. Mar 1, 2017 · Assembly

    Assembly Amendment 2 to Assembly Substitute Amendment 1 offered by Representatives Subeck, Kolste, C. Taylor and Zamarripa

  10. Mar 1, 2017 · Assembly

    Executive action taken

  11. Mar 1, 2017 · Assembly

    Report Assembly Substitute Amendment 1 adoption recommended by Committee on Health, Ayes 10, Noes 2

  12. Mar 1, 2017 · Assembly

    Report passage as amended recommended by Committee on Health, Ayes 10, Noes 2

  13. Mar 1, 2017 · Assembly

    Referred to committee on Rules

  14. Mar 1, 2017 · Assembly

    Placed on calendar 3-7-2017 by Committee on Rules

  15. Mar 3, 2017 · Assembly

    Representative Zamarripa withdrawn as a coauthor

  16. Mar 7, 2017 · Assembly

    Read a second time

  17. Mar 7, 2017 · Assembly

    Assembly Amendment 3 to Assembly Substitute Amendment 1 offered by Representatives Shankland, Hesselbein, Barca, Doyle and Spreitzer

  18. Mar 7, 2017 · Assembly

    Assembly Amendment 3 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34

  19. Mar 7, 2017 · Assembly

    Assembly Amendment 4 to Assembly Substitute Amendment 1 offered by Representatives Subeck, Sargent and Spreitzer

  20. Mar 7, 2017 · Assembly

    Assembly Amendment 4 to Assembly Substitute Amendment 1 laid on table, Ayes 65, Noes 33

  21. Mar 7, 2017 · Assembly

    Assembly Amendment 5 to Assembly Substitute Amendment 1 offered by Representative Shankland

  22. Mar 7, 2017 · Assembly

    Assembly Amendment 5 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34

  23. Mar 7, 2017 · Assembly

    Assembly Amendment 6 to Assembly Substitute Amendment 1 offered by Representative Riemer

  24. Mar 7, 2017 · Assembly

    Assembly Amendment 6 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34

  25. Mar 7, 2017 · Assembly

    Assembly Substitute Amendment 1 adopted

  26. Mar 7, 2017 · Assembly

    Ordered to a third reading

  27. Mar 7, 2017 · Assembly

    Rules suspended

  28. Mar 7, 2017 · Assembly

    Read a third time and passed, Ayes 85, Noes 13

  29. Mar 7, 2017 · Assembly

    Representatives Thiesfeldt, Petryk, Petersen, Summerfield, Ott, Kitchens, Macco, Rohrkaste and Duchow added as coauthors

  30. Mar 7, 2017 · Assembly

    Ordered immediately messaged

  31. Mar 8, 2017 · Senate

    Received from Assembly

  32. Mar 9, 2017 · Senate

    Read first time and referred to committee on Health and Human Services

  33. Aug 16, 2017 · Senate

    Public hearing held

  34. Mar 28, 2018 · Senate

    Failed to concur in pursuant to Senate Joint Resolution 1

Terms on this page

Second chamber's vote

A bill has to pass both the Assembly and the Senate in the same form before it goes to the governor.

Official term: Concurrence. More in the glossary

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1. More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis. More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor. More in the glossary

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor. More in the glossary

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote. More in the glossary

From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source

Second chamber's vote

A bill has to pass both the Assembly and the Senate in the same form before it goes to the governor.

Official term: Concurrence

More in the glossary

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1

More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis

More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor

More in the glossary

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor

More in the glossary

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote

More in the glossary